{"symbol": "MLNT", "companyName": "Melinta Therapeutics Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.melinta.com", "description": "Melinta Therapeutics Inc is a commercial-stage biopharmaceutical company. It is developing antibiotic, Baxdela (delafloxacin), for the treatment of adults with serious skin infections known as acute bacterial skin and skin structure infections.", "CEO": "John H. Johnson", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}